Investors Press Releases Dec 04 2023 Tiziana Life Sciences to Present at the Webull LIVE! with Corporate Connect: Biotech Investment Webinar Read More Nov 30 2023 Tiziana Life Sciences Announces Foralumab Dosing of Four New Patients in the Expanded Access Program for Multiple Sclerosis Read More Nov 01 2023 Tiziana Life Sciences to Present Recent Clinical Updates at BIO-Europe in Munich, Germany, November 6-8, 2023 Read More btn News View All Events & Presentations Dec 14 2023 at 8:30 AM EST Dec 14 2023 at 8:30 AM EST Annual General Meeting 2023 Read More Jun 05 2023 at 12:30 PM EDT Jun 05 2023 at 12:30 PM EDT Tiziana Life Sciences: Foralumab Update in Non-Active Secondary Progressive Multiple Sclerosis (na SPMS) Read More Jan 09 2023 - Jan 11 2023 Jan 09 2023 - Jan 11 2023 Biotech Showcase Read More btn Events View All Interim Reports Interim Results for the Six Months Ended 30 June 2022 641.6 KB bth Interim Reports View All Annual Reports 20 F - Annual Report for the year ended 31 December 2022 4.2 MB btn ARs View All Annual General Meeting Notice of Annual General Meeting December 2023 745.5 KB btn AGM View All Scientific Pipeline Progress Learn more × Stock Quote Change Volume Today's Open Previous Close Today's High Today's Low 52 Week High 52 Week Low Stock Chart
Dec 04 2023 Tiziana Life Sciences to Present at the Webull LIVE! with Corporate Connect: Biotech Investment Webinar Read More
Nov 30 2023 Tiziana Life Sciences Announces Foralumab Dosing of Four New Patients in the Expanded Access Program for Multiple Sclerosis Read More
Nov 01 2023 Tiziana Life Sciences to Present Recent Clinical Updates at BIO-Europe in Munich, Germany, November 6-8, 2023 Read More
Jun 05 2023 at 12:30 PM EDT Jun 05 2023 at 12:30 PM EDT Tiziana Life Sciences: Foralumab Update in Non-Active Secondary Progressive Multiple Sclerosis (na SPMS) Read More